Linda Lofbom
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Journal: Scandinavian journal of immunology
Published: March 26, 2019
Promotion or Suppression of Murine Intestinal Polyp Development by iNKT Cell Directed Immunotherapy.
Promotion or Suppression of Murine Intestinal Polyp Development by iNKT Cell Directed Immunotherapy.
Journal: Frontiers in immunology
Published: August 22, 2018
Innate and adaptive stimulation of murine diverse NKT cells result in distinct cellular responses.
Journal: European journal of immunology
Published: April 13, 2018
Unique invariant natural killer T cells promote intestinal polyps by suppressing TH1 immunity and promoting regulatory T cells.
Journal: Mucosal immunology
Published: November 17, 2016
Administration of sulfatide to ameliorate type I diabetes in non-obese diabetic mice.
Journal: Scandinavian journal of immunology
Published: May 06, 2014
Sulfatide attenuates experimental Staphylococcus aureus sepsis through a CD1d-dependent pathway.
Journal: Infection and immunity
Published: January 24, 2013
CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetes.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: February 29, 2012
Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte.
Journal: European journal of immunology
Published: December 22, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026